Bharat Parenterals Ltd.BSE: BPLPHARMA

Announcement under Regulation 30 (LODR)-Preferential Issue

· Issued by Bharat Parenterals Ltd. via BSE India

Filed with BSE · ISIN INE365Y01019 · · 13 pages · English

Summary by 6ix AI

Bharat Parenterals Ltd. submitted a revised disclosure regarding the voting results from its Extra-Ordinary General Meeting held recently, correcting a categorization error of shareholders in the voting results statement. The revision does not affect the actual votes cast or the outcomes of the resolutions considered at the meeting. The filing includes details of two special resolutions: one for the issuance of equity shares on a preferential basis and another for making investments beyond specified limits.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Ref: Submission dated October 24, 2026. The Company had earlier submitted the voting results of the aforesaid EGM to the Stock Exchanges. While reviewing the voting results, it was observed that certain shareholders falling under the Public – Institutions category were inadvertently included under the Public – Non-Institutions category in the voting-results statement submitted earlier. Accordingly

Bharat Parenterals Ltd. on 6ix

Story so far

Earlier from Bharat Parenterals

Later from Bharat Parenterals

All Bharat Parenterals news releases